Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Congenital Anemias”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03935633
What this trial is testing

Short-term Clinical Study of CN128 in Thalassemia Patients

Who this might be right for
Thalassemia
Hangzhou Zede Pharma-Tech Co., Ltd. 16
Early research (Phase 1)Study completedNCT00001399
What this trial is testing

Gene Therapy for the Treatment of Fanconi's Anemia Type C

Who this might be right for
Fanconi's AnemiaPancytopenia
National Heart, Lung, and Blood Institute (NHLBI) 9
Early research (Phase 1)Study completedNCT03926819
What this trial is testing

Assess the Safety and Pharmacokinetics of HBI-002, an Oral Carbon Monoxide Therapeutic, in Healthy Volunteers

Who this might be right for
Anemia, Sickle Cell
Hillhurst Biopharmaceuticals, Inc. 20
Testing effectiveness (Phase 2)Study completedNCT00014495
What this trial is testing

Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Myeloid Cancer

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
Memorial Sloan Kettering Cancer Center 32
Not applicableStudy completedNCT01831232
What this trial is testing

Idarubicin, Cytarabine, and Pravastatin Sodium in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes

Who this might be right for
Adult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Monoblastic Leukemia (M5a)+16 more
Fred Hutchinson Cancer Center 24
Post-approval studies (Phase 4)UnknownNCT01927029
What this trial is testing

Preterm Delivery Prevention in Twins With Progesterone

Who this might be right for
Pregnancies
Universidad del Desarrollo 213
Testing effectiveness (Phase 2)WithdrawnNCT07155031
What this trial is testing

Biotin-Acridine Red Cell Exchange Kinetics

Who this might be right for
Sickle Cell Disease
Cerus Corporation
Not applicableStudy completedNCT04802629
What this trial is testing

Fetal Haemoglobin and Cerebral and Peripheral Oxygenation.

Who this might be right for
Preterm BirthOxygen ToxicityFetal Hemoglobin
Medical University of Graz 50
Testing effectiveness (Phase 2)Study completedNCT03474965
What this trial is testing

Study of Dose Confirmation and Safety of Crizanlizumab in Pediatric Sickle Cell Disease Patients

Who this might be right for
Sickle Cell Disease (SCD)
Novartis Pharmaceuticals 117
Testing effectiveness (Phase 2)UnknownNCT02061800
What this trial is testing

CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant

Who this might be right for
Chronic Myeloid Leukemia (CML)Acute Myelogenous Leukemia (AML)Myelodysplastic Syndrome (MDS)+3 more
Diane George 14
Not applicableStudy completedNCT03170245
What this trial is testing

Adiponectin, IL-6 and hsC-RP in Relation to Carotid Intima-media Thickness in B-thalassemia Patients

Who this might be right for
Thalassemia
Assiut University 85
Not applicableStudy completedNCT03069430
What this trial is testing

A Self-Management Intervention for Youth With Sickle Cell Disease and Their Families: Phase I

Who this might be right for
Anemia, Sickle Cell
Medical University of South Carolina 44
Large-scale testing (Phase 3)Looking for participantsNCT06975865
What this trial is testing

The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease

Who this might be right for
Sickle Cell Disease
Sanofi 192
Testing effectiveness (Phase 2)Study completedNCT02536170
What this trial is testing

Arginine Therapy for Sickle Cell Disease Pain

Who this might be right for
Sickle Cell DiseaseVaso-occlusive Pain Episode
Emory University 108
Testing effectiveness (Phase 2)Active Not RecruitingNCT06421636
What this trial is testing

Test the Safety, Tolerability, and Efficacy of an Antibody, REGN7999, Injected Under the Skin for the Treatment of Iron Overload in Adult Participants With Non-Transfusion Dependent β-thalassemia, Using MRI Scans to Measure Iron Levels in the Body

Who this might be right for
Non-Transfusion Dependent Beta-Thalassemia (NTDT)
Regeneron Pharmaceuticals 19
Not applicableUnknownNCT04075877
What this trial is testing

FOCUS for Pediatric Sickle Cell Disease and Cancer

Who this might be right for
Pediatric CancerSickle Cell DiseaseQuality of Life+2 more
Georgia State University 60
Not applicableUnknownNCT04705792
What this trial is testing

Physical Rehabilitation in Sickle Cell Anemia

Who this might be right for
Sickle Cell AnemiaMuscle DysfunctionQuality of Life+2 more
Centro Universitário Augusto Motta 40
Early research (Phase 1)UnknownNCT00005896
What this trial is testing

Phase I Pilot Study of CD34 Enriched, Fanconi's Anemia Complementation Group C Gene Transduced Autologous Peripheral Blood Stem Cell Transplantation in Patients With Fanconi's Anemia

Who this might be right for
Fanconi's Anemia
University of Minnesota 6
Not applicableLooking for participantsNCT07725263
What this trial is testing

Low-Dose Liposomal Amphotericin B for Invasive Fungal Infection Prophylaxis in Neutropenic Children

Who this might be right for
ThalassemiaHematopoietic Stem Cell TransplantationNeutropenia+2 more
Haikou Affiliated Hospital of Central South University Xiangya School of Medicine 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT05567458
What this trial is testing

Evaluate Luspatercept (ACE-536) in Chinese Participants Who Require Regular Red Blood Cell Transfusions Due to Beta (β)-Thalassemia.

Who this might be right for
Beta-thalassemia
Bristol-Myers Squibb 94
Next Page